7Baggers
 Published on: 2025-10-03 04:03:28  newser.com Fri, 03 Oct 2025 09:03:28 GMT
 published on: 2025-09-29 16:06:22  newser.com Mon, 29 Sep 2025 21:06:22 GMT
 published on: 2025-09-16 23:37:05  newser.com Wed, 17 Sep 2025 04:37:05 GMT
 published on: 2025-09-16 21:46:32  newser.com Wed, 17 Sep 2025 02:46:32 GMT
 Integrity Alliance LLC. Buys New Shares in Genelux Corporation $GNLX  Defense World Mon, 15 Sep 2025 07:18:15 GMT
 published on: 2025-09-13 11:27:13  newser.com Sat, 13 Sep 2025 16:27:13 GMT
 Genelux Corp. Lowers Stock Option Exercise Prices  The Globe and Mail Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 23:08:03  Newser Thu, 04 Sep 2025 04:08:03 GMT
 Genelux Corp. Lowers Stock Option Exercise Prices  TipRanks Wed, 03 Sep 2025 07:00:00 GMT

Genelux Corp.
(NASDAQ:GNLX) 

GNLX stock logo

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vac...

Founded: 2001
IPO Price: $6 (Jan 26, 2023)
Full Time Employees: 15
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends